UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 574

Sortiert nach

The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment

Brain (London, England : 1878), 2010-01, Vol.133 (1), p.9-22

2010

Volltextzugriff (PDF)

Primary episodic ataxias: diagnosis, pathogenesis and treatment

Brain (London, England : 1878), 2007-10, Vol.130 (10), p.2484-2493

2007

Volltextzugriff (PDF)

The primary periodic paralyses: diagnosis, pathogenesis and treatment

Brain (London, England : 1878), 2006-01, Vol.129 (1), p.8-17

2006

Volltextzugriff (PDF)

Acetazolamide efficacy in hypokalemic periodic paralysis and the predictive role of genotype

Neurology, 2011-11, Vol.77 (22), p.1960

2011

Volltextzugriff (PDF)

Correlating phenotype and genotype in the periodic paralyses

Neurology, 2004-11, Vol.63 (9), p.1647

2004

Volltextzugriff (PDF)

Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy

Neurology, 2001-10, Vol.57 (8), p.1434

2001

Volltextzugriff (PDF)

Andersen's syndrome: A distinct periodic paralysis

Annals of neurology, 1997-09, Vol.42 (3), p.305-312

1997

Volltextzugriff (PDF)

Inclusion body myositis and myopathies

Annals of neurology, 1995-11, Vol.38 (5), p.705-713

1995

Volltextzugriff (PDF)

A randomized efficacy and safety trial of oxandrolone in the treatment of Duchenne dystrophy

Neurology, 2001-04, Vol.56 (8), p.1075

2001

Volltextzugriff (PDF)

A prospective natural history study of inclusion body myositis: implications for clinical trials

Neurology, 2001-08, Vol.57 (3), p.548

2001

Volltextzugriff (PDF)

Early and late losses of motor units after poliomyelitis

Brain (London, England : 1878), 1997-08, Vol.120 (8), p.1415-1421

1997

Volltextzugriff (PDF)

Andersen's syndrome: Potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features

Annals of neurology, 1994-03, Vol.35 (3), p.326-330

1994

Volltextzugriff (PDF)

Improving adherence to dementia guidelines through education and opinion leaders. A randomized, controlled trial

Annals of internal medicine, 1999-08, Vol.131 (4), p.237

1999

Volltextzugriff (PDF)

Effect of testosterone on muscle mass and muscle protein synthesis

Journal of applied physiology (1985), 1989-01, Vol.66 (1), p.498

1989

Volltextzugriff (PDF)

Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: A study of 56 patients

Annals of neurology, 1996-06, Vol.39 (6), p.789-795

1996

Volltextzugriff (PDF)

Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysis

Neurology, 1994-08, Vol.44 (8), p.1500

1994

Volltextzugriff (PDF)

End-plate acetylcholine receptor deficiency due to nonsense mutations in the ε subunit

Annals of neurology, 1996-11, Vol.40 (5), p.810-817

1996

Volltextzugriff (PDF)

Myotonic dystrophy with no trinucleotide repeat expansion

Annals of neurology, 1994-03, Vol.35 (3), p.269-272

1994

Volltextzugriff (PDF)

American Academy of Neurology policy on pharmaceutical and device industry support

Neurology, 2012-03, Vol.78 (10), p.750

2012

Volltextzugriff (PDF)

Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months)

Neurology, 1993-03, Vol.43 (3 Pt 1), p.520

1993

Volltextzugriff (PDF)

Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease

Annals of neurology, 1994-03, Vol.35 (3), p.260-268

1994

Volltextzugriff (PDF)

Mutations in the human skeletal muscle chloride channel gene (CLCN1) associated with dominant and recessive myotonia congenita

Neurology, 1996-10, Vol.47 (4), p.993

1996

Volltextzugriff (PDF)

Mutations in an S4 segment of the adult skeletal muscle sodium channel cause paramyotonia congenita

Neuron (Cambridge, Mass.), 1992-05, Vol.8 (5), p.891-897

1992

Volltextzugriff (PDF)

Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy

The New England journal of medicine, 1989-06, Vol.320 (24), p.1592

1989

Volltextzugriff (PDF)

Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy

Neurology, 1989-04, Vol.39 (4), p.475

1989

Volltextzugriff (PDF)

1 – 25 von 574

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(481)
Mit Volltextzugriff
(410)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(573)
Japanisch
(71)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(372)
Humans
(355)
Life Sciences & Biomedicine
(340)
Male
(211)
Female
(168)
Biological And Medical Sciences
(166)
Adult
(163)
Neurosciences & Neurology
(151)
Clinical Neurology
(145)
Medical Sciences
(144)
Middle Aged
(122)
Adolescent
(97)
Neurology
(79)
Child
(76)
Neurosciences
(66)
Aged
(59)
Animals
(53)
Diseases Of Striated Muscles. Neuromuscular Diseases
(45)
Pharmacology. Drug Treatments
(43)
Child, Preschool
(40)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment

Primary episodic ataxias: diagnosis, pathogenesis and treatment

The primary periodic paralyses: diagnosis, pathogenesis and treatment

Acetazolamide efficacy in hypokalemic periodic paralysis and the predictive role of genotype

Correlating phenotype and genotype in the periodic paralyses

Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy

Andersen's syndrome: A distinct periodic paralysis

Inclusion body myositis and myopathies

A randomized efficacy and safety trial of oxandrolone in the treatment of Duchenne dystrophy

A prospective natural history study of inclusion body myositis: implications for clinical trials

Early and late losses of motor units after poliomyelitis

Andersen's syndrome: Potassium-sensitive periodic paralysis, ventricular ectopy, and dysmorphic features

Improving adherence to dementia guidelines through education and opinion leaders. A randomized, controlled trial

Effect of testosterone on muscle mass and muscle protein synthesis

Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: A study of 56 patients

Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysis

End-plate acetylcholine receptor deficiency due to nonsense mutations in the ε subunit

Myotonic dystrophy with no trinucleotide repeat expansion

American Academy of Neurology policy on pharmaceutical and device industry support

Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months)

Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease

Mutations in the human skeletal muscle chloride channel gene (CLCN1) associated with dominant and recessive myotonia congenita

Mutations in an S4 segment of the adult skeletal muscle sodium channel cause paramyotonia congenita

Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy

Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy

Suchergebnisse filtern